Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
not feeling well after dose 1 of the vaccine; feeling rough after dose 1 of the vaccine; This non-serious case was reported by a physician via sales rep and described the occurrence of feeling unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced feeling unwell (Verbatim: not feeling well after dose 1 of the vaccine) and feeling abnormal (Verbatim: feeling rough after dose 1 of the vaccine). The outcome of the feeling unwell and feeling abnormal were not reported. It was unknown if the reporter considered the feeling unwell and feeling abnormal to be related to Shingrix. It was unknown if the company considered the feeling unwell and feeling abnormal to be related to Shingrix. Additional Information: GSK receipt date: 29-MAY-2025 The patient was approximately 59 year old. The physician reported that he had taken first dose of Shingrix and experienced not feeling well and feeling rough. Despite this, he returned and completed the second dose. He had not described specific symptoms, and he had not stated how long the symptoms had lasted.